Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012-2021

R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : Périodique

Purpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]

Plus d'info

Ajouter à la sélection

Lien externe